KIA
GNMK

Kopp Investment Advisors’s GenMark Diagnostics, Inc GNMK Stock Holding History

Kopp Investment Advisors’s Portfolio GNMK Stock Details GNMK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-81,708
Closed -$992K – 75
2013
Q3 		$992K Sell
81,708
-14,676
-15% -$157K 0.36% 48
2013
Q2 		$997K Buy
+96,384
New +$1.33M 0.39% 48

Other funds holding GNMK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
CRC
Curi RMB Capital Chicago, Illinois $5.62B AUM 18.93% 1-Year Est. Return

Kopp Investment Advisors's GNMK Position: Q4 2013 in Review

Kopp Investment Advisors sold out of GenMark Diagnostics, Inc (GNMK) in Q4 2013, closing a stake of 81,708 shares — an estimated $992K sold.

Kopp Investment Advisors first reported a position in GNMK in Q2 2013 and held it in 2 quarters. The position peaked at $997K in Q2 2013. 78 funds tracked by Wall St. Rank hold GNMK as of Q4 2013.

  • Kopp Investment Advisors reported no remaining GenMark Diagnostics, Inc position as of Q4 2013 after selling out during the quarter.
  • Kopp Investment Advisors sold 81,708 GenMark Diagnostics, Inc shares in Q4 2013, an estimated $992K.
  • Kopp Investment Advisors first reported a position in GenMark Diagnostics, Inc in Q2 2013 and held it in 2 quarters.
  • Kopp Investment Advisors's GenMark Diagnostics, Inc position peaked at $997K in Q2 2013.
  • 78 funds tracked by Wall St. Rank held GenMark Diagnostics, Inc as of Q4 2013.

Based on Kopp Investment Advisors's 13F filing for Q4 2013, filed 21 Jan 2014.